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In a selected subgroup of 50 survivors of cardiac arrest, the
impact of surgical myocardial revascularization on induc-
ible arrhythmias, arrhythmia recurrence and long-term
survival was examined. The effects of several clinical,
angiographic and electrophysiologic variables on arrhyth-
mia recurrence and survival were also analyzed. All pa-
tients had a prehospital cardiac arrest and severe operable
coronary artery disease and underwent myocardial revas-
cularization.
Preoperative electrophysiologic study was performed in
41 patients; 33 (80%) had inducible ventricular arrhyth-
mias. Of 42 patients studied off antiarrhythmic drugs
postoperatively, 19 (45 %) had inducible ventricular ar-
rhythmias. Thirty patients with inducible arrhythmias pre-
operatively underwent postoperative testing off antiar-
rhythmic drugs; arrhythmia induction was suppressed in
14 (47%). By multivariate analysis, the induction of ven·
tricular fibrillation at the preoperative electrophysiologic
study was the only significant predictor of induced ventric-
ular arrhythmia suppression by coronary surgery (p <
The majority of victims of sudden cardiac arrest have been
shown to have severe coronary artery disease (1-5). Only a
minority of these patients have an acute myocardial infarc-
tion at the time of the event (1-3,6,7), and the role of acute
reversible ischemia in precipitating cardiac arrest in the
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0.001). Inducible ventricular fibrillation was not present
postoperatively in any of the 11 patients who manifested
this arrhythmia preoperatively. In contrast, inducible ven-
tricular tachycardia persisted in 80% of patients in whom
preoperative testing induced this arrhythmia.
Patients were followed up for 39 ± 29 months. There
were four arrhythmia recurrences; one was fatal. There
were three nonsudden cardiac deaths and three noncardiac
deaths. By life-table analysis, 5 year survival, cardiac
survival and arrhythmia-free survival rates were 88%,
98%, and 88%, respectively. Depressed left ventricular
ejection fraction and advanced age were predictive of death
(p =0.015 and 0.026, respectively) and cardiac death (p =
0.037 and 0.05, respectively).
In conclusion, in a selected subgroup of survivors of
cardiac arrest, coronary revascularization abolished induc-
ible arrhythmias in a substantial proportion, especially
when the induced arrhythmia was ventricular fibrillation.
Long-term prognosis in these patients is excellent.
(J Am Coli Cardiol1990;15:267-73)
remaining patients is unclear. The majority of these patients
manifest ventricular arrhythmias inducible in the electro-
physiology laboratory, and it is generally accepted that these
arrhythmias may not be suppressed by coronary revascular-
ization alone. Consequently, in patients undergoing surgical
coronary revascularization, additional antiarrhythmic mea-
sures may be planned (for example, automatic defibrillator
implantation, directed endocardial resection). However, in
selected subgroups of survivors of cardiac arrest, coronary
revascularization alone may substantially modulate induc-
ible ventricular arrhythmias.
In a previous report from this institution (8), 60% of
patients with severe, operable coronary artery disease, a
clinical history of ventricular tachycardia or ventricular
fibrillation and inducible ventricular arrhythmias at electro-
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physiologic study had no inducible ventricular arrhythmias
after surgical coronary revascularization alone, without con-
comitant antiarrhythmic surgery. Other investigators (9)
have reported favorable survival data from small subgroups
of survivors of cardiac arrest with operable coronary artery
disease who underwent surgical coronary revascularization.
Therefore, identifying the markers that predict those pa-
tients in whom coronary revascularization is likely to sup-
press ventricular arrhythmias may be important for planning
antiarrhythmic management.
This study examines the short-term effect of coronary
revascularization on inducible ventricular arrhythmias and
its impact on the incidence of arrhythmia recurrence and
long-term survival in a selected subgroup of 50 survivors of
cardiac arrest followed up for a mean of 39 ± 29 months after
coronary artery bypass graft surgery. The effects of several
clinical, angiographic and electrophysiologic variables on
arrhythmia recurrence and survival are analyzed.
Methods
Selection of patients. We analyzed data from all patients
presenting with out-of-hospital cardiac arrest and severe
operable coronary artery disease who 1) underwent coro-
nary artery bypass graft surgery as the sole surgical inter-
vention over an 8 year period, and 2) had electrophysiologic
testing with programmed ventricular stimulation before or
after surgery, or at both of these times.
Study patients. The study group consisted of 50 patients.
There were 41 men and 9 women. All patients had an
out-of-hospital cardiac arrest requiring cardiopulmonary re-
suscitation. No patient had an acute myocardial infarction at
the time of cardiac arrest; 24 had a clinical history of prior
myocardial infarction. Eight patients were performing stren-
uous exercise at the time of the cardiac arrest. Two had
single vessel, 6 had double vessel and 42 had triple vessel
coronary artery disease with>70% reduction of the luminal
diameter of the involved vessels; 7 patients had >50% left
main coronary artery stenosis. The mean (±SD) left ventric-
ular ejection fraction was 46% ± 15% (range 17% to 74%).
Thirty-eight patients had segmental wall motion abnormali-
ties of varying degree, but none had a discrete angiographic
left ventricular aneurysm confirmed at the time of surgery.
None of the patients evolved a perioperative myocardial
infarction. The number of coronary arteries grafted per
patient varied from one to two distal branches in one to three
major epicardial coronary distributions.
Electrophysiologic study protocol. All 50 patients in the
study underwent at least one electrophysiologic testing
before or after coronary artery bypass graft surgery and 33
underwent electrophysiologic testing both before and after
surgery while they were not taking antiarrhythmic drugs.
The stimulation protocol included the introduction of one to
three extrastimuli during ventricular pacing at two basic
Table 1. Variables of Potential Value in Predicting the Effect of
Coronary Revascularization on Arrhythmia Recurrence
and Survival
Age
Gender
Presenting arrhythmia
Presence of left main coronary artery disease
No. of diseased vessels
Left ventricular ejection fraction
Segmental left ventricular wall motion abnormality (hypokinesia)
Segmental left ventricular wall motion abnormality (dyskinesia)
Activity at time of cardiac arrest
No. of arrhythmic events
Arrhythmia inducibility
Antiarrhythmic drug therapy
Beta-blocking drug therapy
cycle lengths at two right ventricular sites. Before June 1982,
triple extrastimuli were not included in the protocol, but
bursts of rapid ventricular pacing (three, four and five
extrastimuli with decremental interectopic intervals until
failure of 1: 1 capture) during normal sinus rhythm were
used. In each patient undergoing two studies, the preopera-
tive and postoperative stimulation protocols were identical.
Moreover, in studies performed before 1982, the end point of
the study was considered to be the induction of ventricular
fibrillation or five or more beats of ventricular tachycardia or
completion of the protocol. From June 1982 to the present,
the end points have been the induction of sustained ventric-
ular tachycardia or ventricular fibrillation or protocol com-
pletion.
Sustained ventricular tachycardia was defined as ventric-
ular tachycardia with a duration of >30 s or associated with
hemodynamic compromise and requiring intervention for
termination. A 12 lead electrocardiogram (ECG) was re-
corded immediately after induction during all tachycardias.
Sustained ventricular tachycardias that manifested no beat
to beat change in cycle length in the frontal and horizontal
axes were called monomorphic.
Patient follow-up. For the 36 patients followed up at this
institution after their operation, follow-up data were ob-
tained by review of inpatient and outpatient medical records.
Fourteen patients were followed up elsewhere, and follow-
up data for these patients were obtained through telephone
contact with the patients and their referring physicians.
Statistical analysis. All data are expressed as mean values
± 1 SD or as proportions. Actuarial analyses of total
survival, cardiac survival and arrhythmia-free survival were
performed using the Kaplan-Meier method. Univariate anal-
yses of the effects of potential risk factors on total survival,
cardiac survival and arrhythmia-free survival were done
using the Fisher exact test (for categorical variables) or the
log-rank test.
Thirteen variables of potential predictive value were
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Figure 1. Flow diagram of 50 patients summarizing the
outcome of baseline programmed cardiac stimulation
(PCS) study performed before coronary revasculariza-
tion and after surgery. Atotal of 41 patients underwent
study before surgery and 44 patients underwent study
after surgery (42 in the absence of antiarrhythmic
drugs). Agroup of 33 patients underwent study without
antiarrhythmic drugs both before and after surgery (bold
arrows). VF = ventricular fibrillation; VT = ventricular
tachycardia.
chosen and analyzed (Table 1). A variable was deemed
significant if the two-tailed p value was <0.05. Multivariate
analyses were performed using a Cox proportional hazards
regression model (10), which was fit from the time of surgery
to the time of first arrhythmia recurrence, cardiac death or
death from any cause (BMDP2L, Department of Biomathe-
matics, University of California, Los Angeles, 1983). Pa-
tients who did not experience these events were censored for
analysis at the number of months since surgery. A stepwise
selection process identified the significant variables.
Postoperative electrophysiologic studies (Fig. 1 and 2).
The effect of surgical coronary revascularization on induced
ventricular arrhythmias could be assessed in a subgroup of
33 patients who, in the absence of antiarrhythmic drug
therapy, underwent cardiac stimulation using the identical
stimulation protocol before and after surgery. Thirty of these
33 patients had inducible ventricular tachycardia (n = 20) or
ventricular fibrillation (n = 10) at preoperative electrophys-
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Figure 2. The outcome of preoperative (PRE-OP) and postoperative
(POST-OP) programmed cardiac stimulation (PCS) study in 33
patients who underwent study in the absence of antiarrhythmic
drugs both before and after coronary revascularization. The results
show a substantial decrease in induced ventricular fibrillation (VF)
and a concomitant increase in the incidence of no ventricular
arrhythmia. VT = ventricular tachycardia.
Results
Preoperative electrophysiologic studies (Fig. 1). Forty-one
patients underwent preoperative baseline electrophysiologic
testing while not taking antiarrhythmic drugs. Nine patients
who did not undergo preoperative programmed cardiac
stimulation included six patients with left main coronary
stenosis, two others thought to be unsuitable for preopera-
tive electrophysiologic study by their physicians because of
clinically unstable coronary artery disease and one patient in
whom programmed cardiac stimulation could not be com-
pleted because of recurrent angina pectoris in the electro-
physiology laboratory. Of the 41 patients studied, 8 had no
inducible arrhythmias during the preoperative study. Twen-
ty-two patients had inducible monomorphic ventricular
tachycardia (3 patients studied before June 1982 had nonsus-
tained monomorphic ventricular tachycardia and 19 had
sustained monomorphic ventricular tachycardia, with rates
varying from 210 to 280 beats/min) and 11 had inducible
ventricular fibrillation (Fig. 1). No tachycardia was hemody-
namically tolerated long enough for ventricular mapping to
be performed.
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iologic study and 3 had no induced ventricular arrhythmia
(Fig. 2). The three patients with no preoperative ventricular
arrhythmia also had no arrhythmia induced after surgery.
Among the 30 patients with inducible ventricular arrhythmia
preoperatively, no ventricular arrhythmia was induced in 14
(47%) (p = 0.00(4) after coronary revascularization. Sixteen
(80%) of the 20 patients with inducible ventricular tachycar-
dia preoperatively had ventricular tachycardia (n = 15) or
ventricular fibrillation (n = I) when studied postoperatively
while not taking antiarrhythmic drugs. None of the 10
patients with inducible ventricular fibrillation at preoperative
electrophysiologic study who underwent postoperative
study had inducible ventricular arrhythmia at the postsurgi-
cal study (Fig. I and 2).
The nine patients who did not undergo preoperative
electrophysiologic testing were studied postoperatively
while not taking antiarrhythmic drugs. Six of these nine
patients had no inducible arrhythmia, two had ventricular
fibrillation and one had sustained ventricular tachycardia
(Fig. I). Of the 19 patients with inducible ventricular ar-
rhythmia (ventricular tachycardia in 16, ventricular fibrilla-
tion in 3) not taking antiarrhythmic drugs postoperatively,
arrhythmia induction was suppressed by antiarrhythmic
drug therapy in 6, as defined by serial testing.
Two patients, both of whom had inducible sustained
ventricular tachycardia at preoperative electrophysiologic
study, underwent postoperative testing only while receiving
antiarrhythmic drug therapy for atrial fibrillation or sponta-
neous nonsustained ventricular tachycardia (Fig. I). Ven-
tricular tachycardia remained inducible in both. One patient
with preoperative inducible ventricular fibrillation could not
be studied after surgery for multiple clinical reasons.
Three of the eight patients with no inducible ventricular
arrhythmias before surgery underwent postoperative pro-
grammed cardiac stimulation and, as before, had no induced
ventricular arrhythmias. The other five patients were not
tested postoperatively (Fig. 1).
In summary, of the 42 patients studied in the absence of
antiarrhythmic drug therapy after coronary revasculariza-
tion, 23 patients (55%) had no inducible ventricular tachyar-
rhythmia (Fig. 1 and 2).
Predictors of arrhythmia suppression. By multivariate
logistic regression analysis, the induction of ventricular
fibrillation at the preoperative electrophysiologic study was
the only significant predictor of a negative postoperative
study among the variables analyzed (p < 0.001). Inducible
ventricular fibrillation was not present after coronary revas-
cularization in any patient who manifested this arrhythmia
preoperatively. In contrast, inducible ventricular tachycar-
dia persisted in the majority of patients in whom preopera-
tive programmed cardiac stimulation resulted in monomor-
phic ventricular tachycardia. Left ventricular ejection
fraction was marginally predictive. The mean ejection frac-
tion in patients with a negative postoperative study was 48 ±
15% versus 39 ± 9% in those with persistently inducible
ventricular arrhythmias (p = 0.06).
Postoperative foUow-up. Patients were followed up for a
mean of 39 ± 29 months after coronary artery bypass graft
surgery. Eighteen patients were discharged on antiarrhyth-
mic drug therapy, including four patients discharged on
amiodarone therapy. In patients in whom inducible arrhyth-
mia could not be suppressed by serial drug testing, antiar-
rhythmic drug therapy was individualized on the basis of
tolerance, effect on ventricular ectopic activity at rest and
observations during electrophysiologic study.
During the follow-up period, one patient had a myocardial
infarction (at 80 months postoperatively), one patient under-
went repeat coronary artery bypass graft surgery (at 35
months) and four patients required hospitalization for con-
gestive heart failure. Two patients had recurrent cardiac
arrest not associated with acute myocardial infarction (Fig.
3); one event was fatal. Another patient had a nonfatal
cardiac arrest in the setting of acute myocardial infarction,
and one patient had sustained monomorphic ventricular
tachycardia without cardiac arrest (Fig. 3). The patient with
recurrent ventricular tachycardia and the one with fatal
cardiac arrest had inducible monomorphic ventricular tachy-
cardia postoperatively. The other patient with arrhythmia
recurrence in the absence of acute myocardial infarction had
negative findings on postsurgical electrophysiologic study.
There were three nonsudden cardiac deaths due to con-
gestive heart failure and three noncardiac deaths (two due to
cancer and one to a motor vehicle accident) (Fig. 3).
By life table analysis, the 1, 2 and 5 year survival rates
were 98%, 95% and 88%, respectively. Cardiac survival was
98% at 5 years and the arrhythmia-free survival rate was 88%
at 5 years (Fig. 3).
By multivariate analysis, depressed left ventricular ejec-
tion fraction and advanced age were the only variables
significantly predictive of death from any cause (p = 0.015
and p = 0.026, respectively) and cardiac death (p = 0.037
and p = 0.05, respectively). The mean left ventricular
ejection fraction was 31 ± 5% in patients who died of cardiac
causes versus 48 ± 16% in those who did not. None of the
variables analyzed was found to be significantly predictive of
arrhythmia recurrence or sudden death.
Discussion
Because coronary artery disease is the underlying disease
in the vast majority of the survivors of out-of-hospital
cardiac arrest, the role of coronary revascularization in the
treatment and prevention of recurrent ventricular arrhyth-
mias is a matter of considerable clinical importance. Previ-
ous reports (9) on small numbers of selected patients sug-
gested that the prognosis for survivors of prehospital cardiac
arrest who undergo coronary artery bypass graft surgery is
favorable.
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In the present investigation, we studied a selected group
of 50 survivors of cardiac arrest who underwent coronary
revascularization as the only surgical intervention and were
followed up for 39 ± 29 months postoperatively. As in a
previous study from this laboratory (8), approximately half
Figure 3. A, Cumulative proportion of the patients free of postop-
erative cardiac arrest or recurrence of sustained ventricular arrhyth-
mias. B, Cumulative proportion of patients without postoperative
death due to a cardiac cause (arrhythmia or heart failure). C,
Cumulative survival showing proportion of postoperative patients
without death due to any cause.
of the patients with inducible ventricular arrhythmia pre-
operatively had no inducible ventricular arrhythmia postop-
eratively, and no patients without preoperative inducible
arrhythmia had a proarrhythmic response postoperatively.
However, ventricular arrhythmia remained inducible after
coronary bypass surgery in 80% of patients with preopera-
tive inducible monomorphic ventricular tachycardia; in con-
trast, ventricular arrhythmia was not inducible after bypass
surgery in any patient with preoperative inducible ventricu-
lar fibrillation who underwent postoperative studies. More-
over, by multivariate analysis, the induction of ventricular
fibrillation, in contrast to monomorphic ventricular tachy-
cardia, at the preoperative electrophysiologic study was the
only significant and independent predictor of a negative
postoperative study. This finding suggests that, independent
of ventricular function, coronary revascularization com-
monly suppresses induced ventricular fibrillation, whereas it
is infrequently effective in suppressing inducible monomor-
phic ventricular tachycardia.
Possible role of reversible ischemia. The persistence of
inducible monomorphic ventricular tachycardia after coro-
nary revascularization is consistent with the presence of
myocardial scarring and an arrhythmogenic milieu that is not
substantially altered by revascularization alone. The same
substrate is probably also responsible for the high reproduc-
ibility of ventricular tachycardia induction in patients with
coronary artery disease and clinical ventricular tachycardia
(11,12). The reproducibility of induced ventricular fibrilla-
tion is less well established. However, it is unlikely that
suppression of induced ventricular fibrillation by coronary
revascularization in our study group is a result of low
reproducibility of a nonspecific response. First, induced
ventricular fibrillation should not be considered a laboratory
artifact in these patients who presented clinically with spon-
taneous ventricular fibrillation not associated with acute
myocardial infarction. Furthermore, it is extremely unlikely
that all episodes of previously present, induced ventricular
fibrillation would be suppressed after surgery if this effect
was solely a result of nonreproducible results. Our findings
suggest a possible causal relation between induced ventric-
ular fibrillation and acute reversible myocardial ischemia in
this subgroup. However, this point remains speculative
because none of the reversible ECG changes of acute
myocardial ischemia were documented in the laboratory and
more sensitive biochemical markers of ischemia were not
investigated.
Factors influencing outcome. Despite persistence of post-
operative inducible arrhythmia in 15 patients, even after
additional therapy with antiarrhythmic drugs, the long-term
survival for this selected group was excellent and substan-
tially exceeded that reported previously (2,6,13,14) for all
survivors of cardiac arrest. Consistent with earlier reports
(15), left ventricular ejection fraction was the most powerful
predictor of cardiac survival, although ventricular function
A
~
1.0 L..,
~ ~ o.a
!4J~
!clJ;::)e: ~ C>.6~~:s:
i:::: ~ 0.4~~
;:::S"~),. 0.2~~q:
ooq:
00
I I I I I
2 3 4 5 6 7 8
B
1.0
-.oJ
§ o.a
:5;:
~,~~0.6.~~~ ,
i:::: a0.4
ooq:'-
~
0.2~~
00 2 3 4 5 6 7 8
C
1.0
-.oJ
§ o.a
:5;:
~~ ~ 0.6
!4J~~ ~
i:::: ~ 0.4
ooq:'-
~~ 0.2~
0
0 2 3 4 5 6 7 8
TIME FROM ENTRY IN YEARS
272 KELLY ET AL.
CORONARY SURGERY AFTER CARDIAC ARREST
lACC Vol. 15, No.2
February t990:267-73
did not predict freedom from arrhythmia recurrence. How-
ever, arrhythmia recurrence was very rare (four patients),
and with a larger study group or longer follow-up period, an
association between ventricular function and recurrence of
ventricular arrhythmia may become apparent. Although the
persistence of inducible ventricular arrhythmia in this se-
lected group of patients was not predictive of overall sur-
vival, cardiac survival or arrhythmia recurrence, the long-
term results in this group compare favorably with those of
previous studies (13,14) in which inducibility of ventricular
arrhythmias was found to be a prognostic factor in the
general population of survivors of cardiac arrest. Surgical
myocardial revascularization, by mechanisms yet poorly
understood, may be modulating the underlying substrate that
plays a role in the initiation and maintenance of ventricular
arrhythmias, without necessarily eliminating it. As a result,
the positive predictive value of programmed cardiac stimu-
lation performed shortly after coronary revascularization
may not be comparable with that observed in other settings,
and the persistence of inducible tachycardia may not neces-
sarily be associated with an ominous prognosis. The clinical
implications of this finding regarding implantation of an
automatic defibrillator. intensive drug therapy or reoperation
with directed scar resection will have to be investigated
using prospective protocols.
Limitations. Several limitations of this study should be
addressed. Most notably, this was a retrospective study of a
selected group of patients with relatively well preserved left
ventricular function and severe proximal coronary artery
disease. The mean left ventricular ejection fraction of 46 ±
15% is higher than that reported in some other series (15,16)
of survivors of cardiac arrest. It is important that all patients
in this series had operable coronary artery disease and none
had a discrete left ventricular aneurysm. Perhaps related to
this factor is the high heart rate (>200 beats/min) observed
during induced ventricular tachycardia in these patients.
Therefore, for these reasons, the results observed in this
selected group may not be generalized to all patients with
prehospital cardiac arrest and should not be compared
directly with the results of the studies describing outcome in
all patients with prehospital cardiac arrest regardless of
cardiac anatomy.
In this study, 18 patients (36%) were treated with antiar-
rhythmic drugs in addition to coronary revascularization.
Despite the lack of statistical correlation between outcome
and antiarrhythmic drug therapy, the use of drug therapy in
a substantial minority of these patients further obscures a
possible relation between pathogenesis of ventricular ar-
rhythmias and reversible acute myocardial ischemia, the
factor most likely to be abolished by coronary revascular-
ization.
Finally, the disparity between the cardiac stimulation
protocol used before June 1982 and that employed after this
date constitutes a methodologic problem. It seems unlikely,
however, that omission of three programmed extrastimuli
before 1982 had any significant effect on the results because
only three patients studied with this protocol had a negative
electrophysiologic study at the time of initial testing and the
presurgical and postsurgical stimulation protocols were iden-
tical in all patients. Furthermore, it is doubtful that the use of
short bursts of ventricular pacing in the early studies repre-
sented too aggressive a stimulation protocol because only
one patient in this seties had an arrhythmia induced by that
method.
Clinical implications. Keeping these limitations firmly in
mind, certain clinical implications of our data can be ad-
dressed. When ventricular arrhythmia is the major, if not the
sole, clinical problem and the patient is a poor candidate for
map-guided ventricular surgery, there is often a need for
other modes of antiarrhythmic therapy, such as further drug
treatment or automatic cardioverter/defibrillator implanta-
tion. According to our data, knowing the response to pro-
grammed cardiac stimulation before coronary revasculariza-
tion may be important in anticipating and planning
postsurgical antiarrhythmic management, even when the
decision for coronary revascularization has already been
made. Patients who have induced ventricular fibrillation but
not monomorphic ventricular tachycardia before surgery,
especially if left ventricular function is relatively well pre-
served, may be the ones least likely to need additional
antiarrhythmic therapy with the implantation of an auto-
matic cardioverter/defibrillator because they appear to have
a low incidence of induced ventricular arrhythmias after the
operation and, furthermore, do well in the long-term follow-
up period without antiarrhythmic drugs. However, our data
will have to be corroborated by similar findings in larger
groups of patients before firm guidelines can be recom-
mended.
Conclusion. This study shows that in a selected subgroup
of survivors of cardiac arrest, coronary revascularization
abolished inducible ventricular arrhythmias in a substantial
proportion, especially when the induced arrhythmia was
ventricular fibrillation and ventricular function was well
preserved. The long-term prognosis in this selected subset of
survivors of cardiac arrest with operable coronary artery
disease who undergo surgical revascularization is excellent.
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